Skip to main content

Table 1 Sociodemographic data and acne severity at baseline visit

From: Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients

 

n

mean (SD)

n (%)

Gender

Male

635

--

240 (37.8 %)

Female

395 (62.2 %)

Age

617

21.3 (7.2)

 

Study level

Primary school

632

--

24 (3.8 %)

Secondary school

151 (23.9 %)

Vocational training (school)

51 (8.1 %)

Pre-university

188 (29.7 %)

Vocational training (technical college)

30 (4.7 %)

First cycle university studies

41 (6.5 %)

Second cycle university studies

146 (23.1 %)

Others

1 (0.2 %)

Physician’s acne evaluation

Without lesions

640

2.47 (0.64)

--

Practically without lesions

32 (5.0 %)

Mild

298 (46.6 %)

Moderate

290 (45.3 %)

Severe

20 (3.1 %)

Patient’s acne evaluation

Without lesions

594

2.10 (0.85)

16 (2.7 %)

Practically without lesions

126 (21.2 %)

Mild

245 (41.2 %)

Moderate

195 (32.8 %)

Severe

12 (2.0 %)

Lesion locationa

Facial

637

--

622 (97.6 %)

Back

212 (33.3 %)

Shoulders

81 (12.7 %)

Presternal area

73 (11.5 %)

Others

2 (0.3 %)

Total number of lesionsa(Percentages of 568 patients with lesions)

Comedones

546

18.9 (20.4)

532 (93.7 %)

Papules/pustules

551

11.4 (10.2)

545 (96.0 %)

Nodules

378

0.9 (1.7)

147 (25.9 %)

Recommendation of specific adjuvant products (facial soaps/cleansers and specific facial care products)

No

640

--

104 (16.3 %)

Yes

536 (83.8 %)

  1. aNon-exclusive categories
  2. N number of patients, SD standard deviation; % = Percentage